Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Ghent University Hospital (UZ)

Status and phase: Completed; Phase 1

Conditions: Head and Neck Tumor

Treatments: Procedure: 18F-FDG-PET radiotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00406289

2006/391

Details and patient eligibility

About

This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.

Enrollment: 24 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Head and neck tumor
• Aged > 18 years

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)